Although we observed nominal associations of genetically proxied TYK2 inhibition with prostate and breast cancer risk in both UK Biobank and FinnGen, the tissue-specific gene expression and colocalization analyses did not confirm these associations. This evidence concerns the gene TYK2 and breast carcinoma.